1. Home
  2. LC vs STOK Comparison

LC vs STOK Comparison

Compare LC & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LendingClub Corporation

LC

LendingClub Corporation

N/A

Current Price

$14.61

Market Cap

2.0B

Sector

Finance

ML Signal

N/A

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

N/A

Current Price

$38.48

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LC
STOK
Founded
2006
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
2008
2019

Fundamental Metrics

Financial Performance
Metric
LC
STOK
Price
$14.61
$38.48
Analyst Decision
Buy
Strong Buy
Analyst Count
6
10
Target Price
$22.67
$36.10
AVG Volume (30 Days)
1.8M
612.3K
Earning Date
04-27-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
157.78
30.67
EPS
1.16
0.85
Revenue
$314,702,000.00
$36,555,000.00
Revenue This Year
N/A
$428.68
Revenue Next Year
$15.91
N/A
P/E Ratio
$12.66
$41.35
Revenue Growth
N/A
316.34
52 Week Low
$7.90
$5.35
52 Week High
$21.67
$39.81

Technical Indicators

Market Signals
Indicator
LC
STOK
Relative Strength Index (RSI) 39.88 65.67
Support Level $12.25 $20.33
Resistance Level $17.41 $39.22
Average True Range (ATR) 0.85 2.41
MACD 0.02 0.30
Stochastic Oscillator 21.68 81.76

Price Performance

Historical Comparison
LC
STOK

About LC LendingClub Corporation

LendingClub Corp is a company engaged in operating an online lending marketplace platform that connects borrowers and investors for the provision of the loan facility. It offers investors access to an asset class that has generally been closed to many investors and only available on a limited basis to institutional investors. The company through the platform offers loan products such as personal, education and patient finance, small business, and auto to interested investors. It generates a majority of the revenue from the transaction fees received from the platform's role in accepting and decisioning applications on behalf of the bank partners to enable loan originations.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: